Skip to main content

Nasdaq Markets

Could Illumina Be a Millionaire-Maker Stock?

6 years 4 months ago
Like peers in the life sciences industry, Illumina (NASDAQ: ILMN) hasn't been immune to the coronavirus outbreak. Shares of the genome sequencing giant fell as much as 37% earlier this year as the outbreak led to a general market crash.
The Motley Fool

2 Pharmaceutical Stocks Trading Below Their Book Value

6 years 4 months ago
You know when a company is in a great deal of trouble when its stock is trading below its book value, defined as the total value of its assets minus all outstanding liabilities. More often than not, such classes of stocks represent significant buying opportunities, as even the t
The Motley Fool

2 Warren Buffett Stocks to Buy in June

6 years 4 months ago
Despite an investor stampede for the exits in the month of March that put a lot of stocks on sale, Warren Buffett's Berkshire Hathaway did surprisingly little stock buying in the first quarter. But the Oracle of Omaha has never been too concerned about passing up opportunities,
The Motley Fool

Better Coronavirus Stock: Abbott Labs or Roche?

6 years 4 months ago
Two of the biggest healthcare giants in the world didn't take very long to jump into the COVID-19 testing waters. Both Abbott Labs (NYSE: ABT) and Roche (OTC: RHHBY) quickly launched diagnostic tests for the novel coronavirus soon after the pandemic hit.
The Motley Fool

2 High-Yield Industrial Stocks I'd Buy Right Now

6 years 4 months ago
The global effort to slow the spread of COVID-19 has resulted in widespread economic shutdowns. That's not good news for industrial stocks, which tend to track along with economic growth. For long-term investors, however, economic weakness could actually be a good time to pick u
The Motley Fool

Is Pfizer a Great Dividend Stock?

6 years 4 months ago
Facing economic uncertainties or prolonged downturns, investors typically seek the safe haven of defensive stocks. Large multinational pharmaceutical companies fall into this category. Illness does not know or care about economic conditions, causing individuals to seek treatment
The Motley Fool

2 Stocks to Bankroll Your Retirement

6 years 4 months ago
Bankrolling your retirement usually entails many years of disciplined saving and investing. It may be difficult to stay the course during challenging times like these. That's why it's important to build around companies that have what it takes to stand the test of time. Walt Di
The Motley Fool

Pfizer Says Breast Cancer Trial Unlikely To Be Effective

6 years 4 months ago
(RTTNews) - Pfizer Inc. (PFE) said that its Phase 3 early breast cancer PALbociclib CoLlaborative Adjuvant trial is unlikely to show a statistically significant improvement in the primary endpoint of invasive disease-free survival. No unexpected new safety signals were observed
RTTNews
Checked
6 minutes 49 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed